Package 50268-128-15

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 50268-128-15
Digits Only 5026812815
Product NDC 50268-128
Product ID 50268-128_47e239f0-069e-a3e1-e063-6294a90a7bf1
Description

50 BLISTER PACK in 1 BOX (50268-128-15) / 1 TABLET in 1 BLISTER PACK (50268-128-11)

Marketing

Marketing Status
Marketed Since 2024-03-19
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Buprenorphine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "47e239f0-069e-a3e1-e063-6294a90a7bf1", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["1408cd8f-a0b5-6be7-e063-6394a90a0b41"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX (50268-128-15)  / 1 TABLET in 1 BLISTER PACK (50268-128-11)", "package_ndc": "50268-128-15", "marketing_start_date": "20240319"}], "brand_name": "Buprenorphine", "product_id": "50268-128_47e239f0-069e-a3e1-e063-6294a90a7bf1", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "50268-128", "dea_schedule": "CIII", "generic_name": "Buprenorphine", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA201760", "marketing_category": "ANDA", "marketing_start_date": "20240319", "listing_expiration_date": "20271231"}